Literature DB >> 17202450

Drugs and valvular heart disease.

Bryan L Roth1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17202450     DOI： 10.1056/NEJMp068265

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  134 in total

1.  HTS and rational drug design to generate a class of 5-HT(2C)-selective ligands for possible use in schizophrenia.

Authors:  Alan P Kozikowski; Sung Jin Cho; Niels H Jensen; John A Allen; Andreas M Svennebring; Bryan L Roth
Journal:  ChemMedChem       Date:  2010-08-02       Impact factor: 3.466

Review 2.  Serotonin and blood pressure regulation.

Authors:  Stephanie W Watts; Shaun F Morrison; Robert Patrick Davis; Susan M Barman
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

3.  5-HT(2B) receptors are required for serotonin-selective antidepressant actions.

Authors:  S L Diaz; S Doly; N Narboux-Nême; S Fernández; P Mazot; S M Banas; K Boutourlinsky; I Moutkine; A Belmer; A Roumier; L Maroteaux
Journal:  Mol Psychiatry       Date:  2011-12-13       Impact factor: 15.992

4.  Irving Page Lecture: 5-HT(2A) serotonin receptor biology: interacting proteins, kinases and paradoxical regulation.

Authors:  Bryan L Roth
Journal:  Neuropharmacology       Date:  2011-02-01       Impact factor: 5.250

Review 5.  The human endogenous metabolome as a pharmacology baseline for drug discovery.

Authors:  Andreu Bofill; Xavier Jalencas; Tudor I Oprea; Jordi Mestres
Journal:  Drug Discov Today       Date:  2019-06-19       Impact factor: 7.851

6.  5-HT2C Receptor Structures Reveal the Structural Basis of GPCR Polypharmacology.

Authors:  Yao Peng; John D McCorvy; Kasper Harpsøe; Katherine Lansu; Shuguang Yuan; Petr Popov; Lu Qu; Mengchen Pu; Tao Che; Louise F Nikolajsen; Xi-Ping Huang; Yiran Wu; Ling Shen; Walden E Bjørn-Yoshimoto; Kang Ding; Daniel Wacker; Gye Won Han; Jianjun Cheng; Vsevolod Katritch; Anders A Jensen; Michael A Hanson; Suwen Zhao; David E Gloriam; Bryan L Roth; Raymond C Stevens; Zhi-Jie Liu
Journal:  Cell       Date:  2018-02-01       Impact factor: 41.582

7.  Pharmacological profile of novel psychoactive benzofurans.

Authors:  Anna Rickli; Simone Kopf; Marius C Hoener; Matthias E Liechti
Journal:  Br J Pharmacol       Date:  2015-04-24       Impact factor: 8.739

8.  Regioselective alkylation of 1,3,4,5-tetrahydrobenzo[d]azepin-2-one and biological evaluation of the resulting alkylated products as potentially selective 5-HT₂c agonists.

Authors:  Navnit Prajapati; Rajani Giridhar; Anshuman Sinha; Ashish M Kanhed; Mange Ram Yadav
Journal:  Mol Divers       Date:  2015-04-28       Impact factor: 2.943

Review 9.  Engineering GPCR signaling pathways with RASSLs.

Authors:  Bruce R Conklin; Edward C Hsiao; Sylvie Claeysen; Aline Dumuis; Supriya Srinivasan; John R Forsayeth; Jean-Marc Guettier; W C Chang; Ying Pei; Ken D McCarthy; Robert A Nissenson; Jürgen Wess; Joël Bockaert; Bryan L Roth
Journal:  Nat Methods       Date:  2008-08       Impact factor: 28.547

Review 10.  Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults.

Authors:  A Giustina; A Barkan; P Chanson; A Grossman; A Hoffman; E Ghigo; F Casanueva; A Colao; S Lamberts; M Sheppard; S Melmed
Journal:  J Endocrinol Invest       Date:  2008-09       Impact factor: 4.256
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.